Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Emergent BioSolutions Inc.

Pharmaceutical Preparations · Gaithersburg, MD, United States

  1. PrincipalsJoseph C PapaPresident and CEORichard S LindahlEVP, Chief Financial OfficerSimon C LowrySVP, R&D, CMOand 8 more
  2. CompanyEmergent BioSolutions Inc.Gaithersburg, MD, United States
  3. Phone line+1 (240) 631-3200General business
Request a quote

Emergent BioSolutions Inc. is an SEC-registered NYSE-listed company (ticker EBS) classified under SIC 2834: Pharmaceutical Preparations.

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions

People 11

Chief executive

Joseph C PapaPresident and CEO

Chair & board

Donald W DeGolyerDirector (Board)
John D Fowler JrDirector (Board)
Ronald RichardDirector (Board)
Sujata Tyagi DayalDirector (Board)

Finance

Richard S LindahlEVP, Chief Financial Officer

Technology & engineering

Simon C LowrySVP, R&D, CMO

Legal

Jessica PerlSVP, General Counsel, Corp Sec
Everyone else on file (3)
Coleen GlessnerEVP, Quality & Ethics, and CPL
Paul Anthony WilliamsSVP, Products Business
William HartzelSVP, Bioservices

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Joseph C Papa — President and CEO

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Richard S Lindahl — EVP, Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Coleen Glessner — EVP, Quality & Ethics, and CPL

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers